- Q4 2023 CorMedix Inc Earnings Call TranscriptMar 12, 2024€3.1 (-3.73%)Earnings
- Q3 2023 CorMedix Inc Earnings Call TranscriptNov 14, 2023€2.86 (+2.88%)Earnings
- CorMedix Inc at HC Wainwright Investment Conference - New York TranscriptSep 13, 2023
- Q2 2023 CorMedix Inc Earnings Call TranscriptAug 08, 2023€3.64 (-2.67%)Earnings
- CorMedix Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- CorMedix Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- CorMedix Inc at JMP Securities Life Sciences Conference TranscriptMay 16, 2023
- Q1 2023 CorMedix Inc Earnings Call TranscriptMay 15, 2023€4.56 (-5.39%)Earnings
- Q4 2022 CorMedix Inc Earnings Call TranscriptMar 30, 2023€3.4 (+9.57%)Earnings
- Q3 2022 CorMedix Inc Earnings Call TranscriptNov 10, 2022€2.77 (-3.04%)Earnings
- Q2 2022 CorMedix Inc Earnings Call TranscriptAug 11, 2022€3.28 (+6.18%)Earnings
- CorMedix Inc at JMP Securities Life Sciences Conference TranscriptJun 15, 2022
- Q1 2022 CorMedix Inc Earnings Call TranscriptMay 12, 2022€2.98 (-5.24%)Earnings
- Q4 2021 CorMedix Inc Earnings Call TranscriptMar 29, 2022€5 (-8.26%)Earnings
- CorMedix Inc Annual Shareholders Meeting TranscriptDec 09, 2021
- Q3 2021 CorMedix Inc Earnings Call TranscriptNov 09, 2021€4.48 (-0.44%)Earnings
- Q2 2021 CorMedix Inc Earnings Call TranscriptAug 12, 2021€4.86 (-2.80%)Earnings
- Q1 2021 CorMedix Inc Earnings Call TranscriptMay 13, 2021€6.25 (-5.30%)Earnings
- Q4 2020 CorMedix Inc Earnings Call TranscriptMar 30, 2021€7.2 (+0.70%)Earnings
- CorMedix Inc. - Special Call TranscriptMar 09, 2021
- CorMedix Inc Annual Shareholders Meeting TranscriptDec 16, 2020
- Q3 2020 CorMedix Inc Earnings Call TranscriptNov 05, 2020€4.5Earnings
- Q2 2020 CorMedix Inc Earnings Call TranscriptAug 10, 2020€3.66 (-0.54%)Earnings
- CorMedix Inc. - Special Call TranscriptMay 19, 2020
- Q1 2020 CorMedix Inc Earnings Call TranscriptMay 11, 2020€3.8 (+6.15%)Earnings
- Q4 2019 CorMedix Inc Earnings Call TranscriptMar 16, 2020€3.44 (+0.58%)Earnings
- Q3 2019 CorMedix Inc Earnings Call TranscriptNov 14, 2019€4.8 (+2.13%)Earnings
- Q2 2019 CorMedix Inc Earnings Call TranscriptAug 13, 2019€7.19 (-2.57%)Earnings
- Q1 2019 CorMedix Inc Earnings Call TranscriptMay 13, 2019Earnings
CorMedix Inc at RBC Capital Markets Global Healthcare Conference Transcript
Welcome to the 2023 RBC Global Healthcare Conference. I'm Rahul Sood, managing director in the healthcare investment banking group. And I'm joined on the stage today by Joe Todisco, the CEO of CorMedix. Joe, thanks for joining.
Thank you.
Questions & Answers
Okay. So for those of us who aren't familiar with the CorMedix story, can you please provide us with a brief intro of the company and the lead asset, DefenCath, specifically, how DefenCath differentiated from the current products and procedures in place to protect against catheter-related bloodstream infections?
All right. Sure. Thanks. Well, thanks, those of you that are in here, for joining.
So CorMedix is a pre-commercial stage biotech company. And our lead product, DefenCath, the NDA was just resubmitted to FDA this past Monday. So the product
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)